BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home » Blogs » BioWorld MedTech Perspectives » MDD's Top 10 deals (so far) of '11

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology

MDD's Top 10 deals (so far) of '11

July 14, 2011
By Amanda Pedersen
Dollars seamless background.

Now that the first half of 2011 is already in our rearview mirror, Medical Device Daily has compiled a Top 10 list of the biggest deals so far this year. Admittedly, the list was inspired by the excitement of last week’s dealmaking activity – Medtronic to spend a total of $645 million to buy Salient Surgical Technologies and PEAK Surgical and TPG Capital buying Immucor for $1.97 billion.

So without further ado, here are the Top 10 deals MDD has reported on so far this year, not including any deals that closed this year but were first disclosed last year.

10. TPG Capital (Fort Worth, Texas) is buying Immucor (Norcross, Georgia) for $1.97 billion.

9. Health Care REIT (Toledo, Ohio) bought Genesis Healthcare (Kennett Square, Pennsylvania) for $2.4 billion.

8. Endo Pharmaceuticals (Chadds Ford, Pennsylvania) bought American Medical Systems (Minnetonka, Minnesota) in a $2.9 billion deal.

7. Ventas (Chicago) acquired 118 private-pay senior housing communities of Atria Senior Living Group (Louisville, Kentucky) for $3.1 billion.

6. Emergency Medical Services (Greenwood Village, Colorado) has agreed to be bought out by an affiliate of Clayton, Dubilier & Rice for $3.2 billion.

5. Thermo Fisher Scientific (Waltham, Massachusetts) seeks to acquire Phadia (Uppsala, Sweden) for roughly $3.5 billion.

4. A consortium of private equity investors plan to buy Kinetic Concepts (San Antonio) for $6.3 billion.

3. Danaher (Washington) plans to buy Beckman Coulter (Brea, California) for $6.8 billion.

2.  Ventas says it will acquire Nationwide Health Properties (New Port Beach, California) in a $7.4 billion stock-for-stock deal.

1. Johnson & Johnson (New Brunswick, New Jersey) says it will pay $21.3 billion for Synthes (Solothurn, Switzerland), making it one of the largest med-tech deals in history.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • Cancer cell in the cross-hairs

    Selective CBL-B inhibitor with improved safety profile disclosed

    BioWorld Science
    CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing